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OBJECTIVE—Low birth weight (LBW) is associated with in-
creased risk of obesity, diabetes, and cardiovascular disease during
adult life. Moreover, this programmed disease risk can progress to
subsequent generations. We previously described a mouse model of
LBW, produced by maternal caloric undernutrition (UN) during late
gestation. LBW offspring (F1-UN generation) develop progressive
obesity and impaired glucose tolerance (IGT) with aging. We aimed
to determine whether such metabolic phenotypes can be transmit-
ted to subsequent generations in an experimental model, even in the
absence of altered nutrition during the second pregnancy.
RESEARCH DESIGN AND METHODS—We intercrossed fe-
male and male F1 adult control (C) and UN mice and character-
ized metabolic phenotypes in F2 offspring.
RESULTS—We demonstrate that 1) reduced birth weight
progresses to F2 offspring through the paternal line (C-C 
1.64 g; C-UN  1.57 g, P  0.05; UN-C  1.64 g;
UN-UN  1.60 g, P  0.05), 2) obesity progresses through the
maternal line (percent body fat: C-C  22.4%; C-UN 
22.9%; UN-C  25.9%, P  0.05; UN-UN  27.5%, P 
0.05), and 3) IGT progresses through both parental lineages
(glucose tolerance test area under curve C-C  100; C-UN
 122, P  0.05; UN-C  131, P  0.05; UN-UN  151, P 
0.05). Mechanistically, IGT in both F1 and F2 generations is linked to
impaired -cell function, explained, in part, by dysregulation of
Sur1 expression.
CONCLUSIONS—Maternal undernutrition during pregnancy
(F0) programs reduced birth weight, IGT, and obesity in both
ﬁrst- and second-generation offspring. Sex-speciﬁc transmission
of phenotypes implicates complex mechanisms including alter-
ations in the maternal metabolic environment (transmaternal
inheritance of obesity), gene expression mediated by develop-
mental and epigenetic pathways (transpaternal inheritance of
LBW), or both (IGT). Diabetes 58:460–468, 2009
H
uman and animal studies have demonstrated a
strong association between intrauterine growth
retardation/low birth weight (LBW) and in-
creased susceptibility to cardiovascular dis-
ease, obesity, and type 2 diabetes during adult life (1–5).
This association has been conceptualized by the develop-
mental programming hypothesis, which proposes that
environmental stimuli acting during critical windows of
development, including fetal and/or early postnatal peri-
ods, can induce permanent alterations in cell/tissue struc-
ture and function (5).
A growing body of epidemiologic evidence indicates
that the effects of developmental programming can be
perpetuated to subsequent generations, even in the
absence of further environmental stressors during intra-
uterine and early postnatal life (6,7). For example,
offspring of LBW humans also have reduced birth weight
(8), increased cardiovascular risk factors (8), and in-
creased susceptibility to metabolic syndrome and type 2
diabetes (7). Similarly, intergenerational effects on birth
weight, glucose tolerance, and hypothalamic function have
been demonstrated in rat models of fetal programming
(9–13). While multiple mechanisms may link nutritional
imbalance during early life with transgenerational trans-
mission of metabolic phenotypes, epigenetic mechanisms
have gained particular prominence for several reasons
(14–16). First, alterations in nutrition during develop-
ment can alter epigenetic marks, including DNA meth-
ylation (12,17–19) and histone modiﬁcations (17,20,21)
in rodents. Second, epigenetic marks are stable and can
be inherited in somatic cells through mitosis or, if
occurring in the germ line, through meiosis (22–24).
Thus, inheritance of nutritionally induced epigenetic
modiﬁcations through meiosis may contribute to inter-
generational effects.
We have previously described a mouse model of intra-
uterine growth restriction induced by maternal global
caloric restriction during pregnancy (25,26). LBW males
develop severe glucose intolerance with aging (25), with
major contributions from both obesity and impaired -cell
function. To assess intergenerational effects in this model,
we intercrossed F1 males and females to 1) evaluate
adiposity and ß-cell function in second-generation off-
spring and 2) to determine whether intergenerational
inheritance is transmitted through the maternal and/or
paternal line. Finally, we assessed expression of candidate
genes potentially regulated by epigenetic mechanisms
which might contribute to metabolic phenotypes in ﬁrst-
and second-generation offspring.
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460 DIABETES, VOL. 58, FEBRUARY 2009RESEARCH DESIGN AND METHODS
Protocols were approved by the Joslin Diabetes Center Institutional Animal
Care and Use Committee. Virgin ICR females (6–8 weeks old, parental
generation F0) were caged with ICR males (Fig. 1A). Pregnancy was dated by
vaginal plug (day 0.5). Pregnant F0 females were housed individually with ad
libitum access to Purina 9F chow. On pregnancy day 12.5, F0 females were
assigned to either control (C) or undernutrition (UN) groups randomly. Food
intake of F0-UN dams was restricted from day 12.5 until delivery by 50%
compared with that consumed by F0 controls (25). Litters were equalized to
eight pups per dam by removing both the heaviest and lightest mice in the
litter, thus retaining those with birth weight closest to the median for each
litter. Offspring of F0 mice were designated as ﬁrst-generation offspring (F1)
(Fig. 1A). After delivery, all F0 mothers received chow ad libitum. F1 pups
nursed freely and were weaned at 3 weeks onto 9F chow, provided ad libitum.
C and UN females from the F1 generation were mated at age 2 months with
nonsibling F1-C or F1-UN males to generate four experimental groups (Fig.
1A). After conﬁrmation of pregnancy, females were caged individually and fed
ad libitum with no dietary manipulation during pregnancy. Pups were desig-
nated as second-generation offspring (F2): C-C (both parents are controls);
C-UN (female control, male UN); UN-C(female UN, male control); and
UN-UN (both parents UN). F2 mice were weaned at 3 weeks onto 9F chow
ad libitum; only males were followed for metabolic analysis given the higher
prevalence of diabetes in UN-F1 males (100 vs. 30% in females, as described
[25]).
In vivo metabolic testing. Intraperitoneal glucose (2 g/kg weight) and
insulin tolerance (1 unit/kg) tests were performed in unrestrained conscious
mice after a 16- and 4-h fast, respectively. Intraperitoneal tolbutamide
tolerance (1 mg/kg) was assessed after a 4-h fast.
Islet isolation and insulin secretion. Islets were isolated from 4-month-old
mice following intraductal collagenase infusion as previously described (25).
For indicated experiments, diazoxide and tolbutamide (Sigma) were added
during incubation (ﬁnal concentration 250 and 200 mol/l, respectively).
Gene expression (quantitative PCR). Total RNA was isolated using
RNeasy (Qiagen) and cDNA was synthesized using oligo-dT primers (Advan-
tage; Clontech) for real-time quatitative PCR with SybrGreen detection (ABI
Prism 7700; Applied Bioscience). Full list of primer sequences is available in
supplementary Table 1 (available at http://dx.doi.org/10.2337/db08-0490) .
DNA methylation. Methylation of the Sur1 promoter was analyzed by PCR
(MethylScreen; Orion Genomics) (27) (supplementary METHODS), while meth-
ylation of differentially methylated regions at the Pref1 locus was assessed by
Southern blotting (28).
Body composition. Body composition was analyzed by dual-energy X-ray
absorptiometry (Hologic, Waltham, MA) (29).
Serum analysis. Blood samples from adult mice were collected from the tail
vein, while trunk blood was collected from ED16.5 fetuses after decapitation.
Blood glucose was measured with Glucometer Elite (Bayer, Elkhart, IN).
Insulin, leptin (enzyme-linked immunosorbent assay; Crystal Chem), triglyc-
erides, glycerol (GTO-Trinder Triglycerides assay; Sigma), and nonesteriﬁed
fatty acids (Half-micro test; Roche) were measured on 2- to 5-l serum
samples.
Statistical analysis. Data are expressed as means  SE. Statistical analysis
was performed using a two-tailed t test or ANOVA (Statview). P  0.05 was
considered signiﬁcant.
RESULTS
Intergenerational inheritance of body weight. As pre-
viously described, 50% global caloric restriction of F0 dams
during the last week of gestation blunted feto-maternal
growth and resulted in 15% decrease in offspring birth
weight (F1-UN) (25). In pregnancies of F1 mice, both
maternal food intake and feto-maternal weight gain (sup-
plementary Table 2) were similar among the four experi-
mental groups. Despite this, birth weight was modestly,
but signiﬁcantly, reduced in C-UN and UN-UN
offspring compared with C-C (Fig. 1B); UN-C mice
had normal birth weight compared with controls. Litter
size and length of gestation were similar in all groups
(supplementary Table 2). After delivery, all four F2 groups
had similar weights to 40 weeks (Fig. 1C).
Since feto-maternal nutritional status during pregnancy
might account for observed differences in birth weight, we
determined both maternal and fetal serum concentrations
of major macronutrients contributing to fetal growth. In
F0-UN females, caloric restriction resulted in 34% reduc-
tion in serum glucose and 80% reduction in triglycerides by
day 16.5 of gestation (P  0.05, Table 1). Likewise, serum
insulin and leptin were reduced in F0-UN dams by 77 and
94%, respectively (P  0.05) (Table 1). Maternal dysregu-
lation of fuel metabolism was also accompanied by alter-
ations in fetal metabolism. Fetal glucose and leptin levels
were decreased by 45 and 63%, respectively, in ED16.5
F1-UN fetuses (P  0.05) (Table 2), while triglycerides,
free fatty acids (FFAs), glycerol, and insulin did not differ
from controls (not shown).
By contrast, during the F1 generation pregnancy, mater-
nal glucose, triglycerides, FFAs, insulin, and leptin did not
differ between groups at pregnancy day 16.5 (Table 1).
However, serum glycerol was increased by 49 and 59% in
dams of C-UN and UN-C pregnancies, respectively
(P  0.05) compared with C-C (Table 1). Despite no
major differences in maternal metabolism, we observed
some differences in ED16.5 F2 fetuses. Glucose levels were
increased by 66% in UN-UN fetuses (P  0.05), and
insulin increased by 41% in C-UN fetuses (P  0.05)
(Table 2). There were no signiﬁcant differences in
UN-C fetuses.
Intergenerational inheritance of glucose intolerance.
Glucose levels in F2 males did not differ in either fed (Fig.
2A) or fasting conditions (supplementary Fig. 1A)u pt o1 0
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FIG. 1. Experimental design, birth weight, and growth curves. A: Experimental design, including breeding scheme for second-generation (F2)
offspring. Circles designate females and squares designate males. Note that mating pairs were nonsiblings. Metabolic analysis was performed in
males only. B: Body weight at birth for F2 offspring. C: Postnatal growth curves for F2 male mice. For all panels, values are means  SE (n > 15
mice/group). *P < 0.05; **P < 0.01 vs. C-C (ANOVA).
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glycerol, and FFAs were also similar among the four F2
groups at 2 and 4 months (not shown). However, UN-
UN, but not C-UN or UN-C mice, developed
hyperinsulinemia in the fed state between 4 and 8 months
of age (P  0.05) (Fig. 2B). Fasting insulin was similar in
all F2 groups (supplementary Fig. 1B). To better deﬁne
glucose homeostasis, we performed intraperitoneal glu-
cose tolerance testing in all F2 mice. Strikingly, glucose
tolerance was impaired (relative to C-C)i nC -UN,
UN-C, and UN-UN mice between 4 and 6 months of
age (P  0.03, P  0.003, and P  0.007, respectively) (Fig.
3A).
We next explored potential mechanisms responsible
for glucose intolerance in F2 offspring of UN parents.
UN-UN mice were clearly insulin resistant (assessed
by insulin tolerance) by age 6 months (P  0.001) (Fig.
3B). By contrast, C-UN and UN-C mice exhibited
normal insulin sensitivity.
Since glucose intolerance may also reﬂect dysregulation
of insulin secretion, we assessed glucose-stimulated insu-
lin secretion in vivo and ex vivo. We ﬁrst measured serum
insulin with fasting and 30 min after a glucose load
(glucose tolerance test) (Fig. 4A); glucose-stimulated in-
sulin secretion was reduced in F2 offspring from F1-UN
parents compared with C-C mice at age 4 months (P 
0.05 for all comparisons) (Fig. 4A). Likewise, ex vivo
glucose-stimulated insulin secretion was also impaired in
islets from 4-month-old UN-C and UN-UN mice
(P  0.05 for both) but not C-UN mice (Fig. 4B). Thus,
reduced glucose-stimulated insulin secretion may also
contribute to impaired glucose tolerance (IGT) in F2 mice.
One potential candidate underlying insulin secretory
dysfunction in F2 mice is altered expression and/or func-
tion of the -cell ATP-dependent K
 channel, composed of
Sur1/Kir6.2 subunits. We assessed the functional capacity
of this complex using in vivo challenge with the sulfonyl-
urea tolbutamide (1 mg/kg i.p.). Tolbutamide induced a
15% increase in serum insulin after 30 min in C-C mice
(P  0.05) (Fig. 4C) (supplementary Fig. 2A). In contrast,
F2 offspring from UN parents had impaired tolbutamide
response (Fig. 4C) (supplementary Fig. 2A). Paralleling in
vivo data, tolbutamide stimulated insulin release from
freshly isolated C-C islets by ﬁvefold (Fig. 4D), while
responses in all other groups were signiﬁcantly reduced,
with only minor increments in C-UN and UN-UN
islets and no effect in UN-C islets (Fig. 4D). We also
incubated islets with diazoxide, a potassium channel stim-
ulator. Diazoxide tended to reduce insulin release from
C-C islets (50%, P  0.1) (supplementary Fig. 2B).
Interestingly, response in UN-C islets was nearly nor-
mal, but diazoxide had only minimal effect in C-UN and
UN-UN islets (5–10% decrease) (supplementary Fig.
2B). Together, these data suggest that dysfunctional po-
tassium channel activity may contribute to impaired insu-
lin secretion in F2 mice.
To determine whether alterations in expression might
contribute to dysfunction of potassium channels, we as-
sessed Sur1 and Kir6.2 expression in isolated islets. Sur1
expression was reduced by 23% (P  0.05) in F1-UN islets
(Fig. 4E). Likewise, Sur1 expression was reduced by 33%
in C-UN (P  0.05), by 56% in UN-C(P  0.05), and
by 38% in UN-UN islets (P  0.05) (Fig. 4E). By
contrast, Kir6.2 expression was normal in both F1 and F2
islets (Fig. 4F).
Since epigenetic regulation at the Sur1 locus might be
mechanistically linked to differential expression in F2
offspring of LBW mice, we assessed DNA methylation
TABLE 1
Maternal physiology at day 16.5 of pregnancy
F0 dams F1 dams
Control Undernourished
Control female 
control male
Control female 
undernourished
male
Undernourished
female 
control male
Undernourished
female 
undernourished
male
Blood glucose (mg/dl) 99  36 5  4* 111  6 103  5 105  4 108  4
Serum insulin (ng/ml) 0.84  0.33 0.19  0.13* 1.6  0.36 1.7  0.22 2.0  0.41 1.4  0.34
Serum leptin (ng/ml) 7.2  1.9 0.42  0.22* 32.9  0.6 34.3  0.5 38.7  14 38.4  6.8
Serum TG (mg/dl) 218  29 44  27* 156  47 202  15 210  47 185  23
Serum glycerol (mg/dl) 41.8  5.7 32.4  5.9 37  5.1 55  10.5* 59  6.8* 51  5.7
Serum FFAs (mmol/l) 1.2  0.17 1.0  0.13 1.2  0.20 1.5  0.19 1.6  0.23 1.4  0.24
Data are means  SE. Maternal serum levels of hormones and nutrients at pregnancy day 16.5. *P  0.05 vs. controls. Signiﬁcance was
determined by Student’s t test in F0 dams and ANOVA in F1 dams. TG, triglycerides.
TABLE 2
ED16.5 serum metabolites
F1 offspring F2 offspring
Control Undernourished
Control female–
control male
Control female–
undernourished
male
Undernourished
female	
control male
Undernourished
female–
undernourished
male
Blood glucose (mg/ dl) 20  31 1  2* 26.4  3.1 31.9  3.4 30.0  14 43.9  5.2*
Serum insulin (pg/ml) 216  26 230  28 221  27 312  27* 307  21 316  33
Serum leptin (pg/ml) 263  48 96  28* 379  237 321  99 192  203 695  124
Data are means  SE. Fetal serum levels of glucose, insulin, and leptin at embryonic day 16.5. *P  0.05 vs. controls. Signiﬁcance was
determined by Student’s t test in F1 offspring and ANOVA in F2 offspring.
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tion-sensitive PCR (27); we did not detect differential
methylation in either F1 (Supplementary Fig. 3) or F2 islets
(not shown).
Intergenerational inheritance of obesity. We have
previously shown that F1-UN males develop increased
adiposity as early as 2 months of age (26). In the F2
generation, both maternal lineage offspring groups de-
veloped increased adiposity by 4 months (P  0.05)
(Fig. 5A). Interestingly, adiposity in UN-UNmice is
largely visceral in location (Fig. 5A). In parallel, serum
leptin is increased in UN-UN mice (P  0.05) (Fig.
5B). We observed no differences in epididymal adipo-
cyte size distribution or histology (not shown) or in
adipose expression of genes regulating differentiation
and/or metabolic function, including peroxisome prolif-
erator–activated receptor 
, CCAAT/enhancer binding
protein , fatty acid binding protein 4, and Glut4, from
any F2 group at 4 months of age (supplementary Table 3).
Since obesity in UN-UN mice implicates a contribu-
tion from epigenetic factors, we determined expression of
imprinted genes known to regulate adipocyte development
and/or function and thus potentially contributing to obe-
sity, including preadipocyte factor 1 (Pref1) (30), Necdin
(31), and paternally expressed gene 1 (Peg1) (32). Pref1,
an inhibitor of adipogenesis expressed from the paternally
inherited chromosome, was reduced in epididymal fat
from F1-UN males (P  0.05) and from both paternal F2
lineages, C-UN and UN-UN (P  0.01) (Figs. 5C
and D). This effect appeared restricted to Pref1 since
expression of Necdin and Peg1, also paternally ex-
pressed, was not statistically different from controls in
either F1 or F2 offspring (Figs. 5C and D). In addition,
expression of retrotransposon-like 1 (Rtl1) and mater-
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DIABETES, VOL. 58, FEBRUARY 2009 463nally expressed 2 (Gtl2), two genes also regulated by the
same imprinting signals as Pref1 (28), did not differ
among groups in F1 and F2 offspring (not shown).
To determine whether changes in Pref1 gene expression
were related to differential methylation at this imprinted
locus, we assessed DNA methylation by Southern blotting.
We did not detect any alterations in DNA methylation at
the Pref1 differentially methylated region, the intergenic
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region (supplementary Fig. 4A and B).
DISCUSSION
Human data indicate that metabolic phenotypes associ-
ated with exposure to maternal undernutrition can also be
observed in second-generation offspring. Conceptually,
transgenerational inheritance of disease risk may be me-
diated by nongenomic mechanisms, including either 1)
epigenetic mechanisms (16) or 2) other broader indirect
mechanisms associated with parental physiology (rev. in
6). First, alterations in nutrition during development can
alter epigenetic marks, thus regulating gene expression
through DNA methylation (12,17–19) and/or histone mod-
iﬁcations (17,20,21). Interestingly, such epigenetic modiﬁ-
cations may progress with aging during postnatal life, in
association with metabolic phenotypes, as recently ob-
served at the pancreatic duodenal homeobox-1 and GLUT4
locus in rodent models of intrauterine programming (33–
35). If these epigenetic changes occur in the germ line,
they can be inherited through meiosis (22–24), thus pro-
viding a plausible explanation for intergenerational effects,
transmitted via either maternal or paternal lines.
In addition, other indirect biological processes may
inﬂuence phenotypes in subsequent generations. For ex-
ample, uterine size is reduced in girls that are born small
(F1) and remain short (36); this may inﬂuence fetal growth
and reduce weight in their progeny (F2) (rev. in 6).
Therefore, physical constraints may alter birth size
through the maternal lineage. Furthermore, maternal
metabolism may also inﬂuence cross-generational pheno-
types (37). Maternal undernutrition during pregnancy (F0)
increases risk for developing diabetes and obesity in her
offspring (F1). When these high-risk adult F1 females
become pregnant, the metabolic stress of pregnancy may
result in hyperglycemia and/or overt gestational diabetes
that may, in turn, contribute to fetal hyperinsulinemia,
obesity, and increased diabetes risk in F2 offspring (37).
UN, F1
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phenotypes would occur exclusively through the maternal
lineage, as opposed to epigenetic mechanisms.
Since it is difﬁcult to dissect the relative parental
contributions and the molecular mechanisms that lead to
F2 offspring outcomes in humans, we have utilized our
mouse model of maternal undernutrition during pregnancy
to address these important questions. We have previously
shown that global caloric restriction during the last week
of gestation in pregnant females (F0) impairs fetal growth,
resulting in 15–20% reduction in birth weight, and the
development of both obesity and glucose intolerance in F1
offspring (25,26). These alterations are multifactorial in
origin, with glucose intolerance mediated, in part, by
impaired glucose-stimulated insulin secretion (25). We
now demonstrate that metabolic phenotypes are also
observed in the F2 generation: 1) reduced birth weight
progresses from F1 to F2 through the paternal, but not the
maternal, line (Fig. 1B); 2)F 2 offspring of both F1-UN
males and females develop IGT with aging, in parallel with
-cell dysfunction (Figs. 3A and 4A and B) and, in UN-
UN, insulin resistance (Figs. 2B and 3B); and 3) obesity
progresses through the maternal, but not the paternal,
lineage (Fig. 5A).
Intergenerational transmission of LBW. Maternal un-
dernutrition (F0) during the last week of gestation results
in reduced birth weight in both F1 (25) and F2 offspring of
F1-UN males (C-UN and UN-UN) but not offspring
of F1-UN females (UN-C) (Fig. 1B). Such patrilineal
inheritance of reduced birth weight may be attributed to
alterations in fetoplacental gene expression and/or func-
tion, most likely mediated by epigenetic modiﬁcations.
While we did not detect major metabolic dysregulation in
C-UN and UN-UN mice at embryonic day 16.5
(Tables 1 and 2), it is likely that more subtle or time-
dependent effects on placental function account for pater-
nally mediated reductions in birth weight in this setting.
While experimental (9,11,38,39) and human (40,41) data
show similar paternal transmission patterns of birth
weight, population-based studies also indicate that inter-
generational aggregation of LBW can also occur through
maternal lineages (40,41). Such results may reﬂect species
differences and complex inﬂuences on human birth weight
(e.g., genetics, maternal size). Furthermore, human popu-
lation data generally exclude complicated pregnancies
(e.g., gestational diabetes) and thus may also exclude the
impact of fetal “overgrowth” due to increased nutrient
supply in the context of previous maternal LBW.
Intergenerational transmission of glucose intoler-
ance. F1-UN males exhibit moderate hyperglycemia and
IGT with aging and dysregulated glucose-stimulated insu-
lin secretion (25). Additionally, all F2 offspring of F1-UN
parents develop glucose intolerance by age 4 months (Fig.
3A). Therefore, intergenerational progression of glucose
intolerance can derive from both the maternal and pater-
nal lines. While maternal and grandmaternal inheritance of
diabetes has been demonstrated in rats (9,11,38,39), here
we present the ﬁrst experimental evidence for transgen-
erational transmission of IGT also through the paternal
lineage. In agreement, paternal LBW in humans has re-
cently been linked to risk of metabolic syndrome in both
offspring and grandoffspring (7).
We previously demonstrated that impaired glucose-
stimulated insulin secretion is an early key phenotype in
F1-UN males (25). Multiple metabolic adaptations lead to
-cell dysfunction in F1-UN mice, including altered glu-
cokinase, hexokinase-1, and ATP-dependent K
 channel
activities (25) (J.C.J.-C., unpublished data). We now ﬁnd
that glucose-stimulated insulin secretion is also impaired
in islets of F2 mice from UN parents and is likely a major
contributor to glucose intolerance (Fig. 4A and B). Addi-
tionally, we show that potassium channel activity is also
altered in islets from F2-UN offspring both in vivo and in
vitro (Fig. 4C and D; supplementary Fig. 2A and B). Thus,
it is interesting that expression of Sur1 is reduced by 30%
in islets from both F1-UN mice and islets from F2 C-
UN,U N -UN, and UN-UN mice (Fig. 4E), indicat-
ing that dysregulation of Sur1 gene expression and
function can be transmitted to F2 through both maternal
and paternal lines. This effect was speciﬁc to Sur1, since
Kir6.2 gene expression was normal in both F1 and F2 islets
(Fig. 4F). Together, these data suggest that dysregulation
of Sur1 expression may alter potassium channel function
(42) and ultimately contribute to whole-body glucose
intolerance in our model. In agreement, genetic ablation of
Sur1 results in metabolic phenotypes similar to those of
our mouse model. Sur1
	/	 mice remain euglycemic for
the majority of their lifespan, displaying moderate glu-
cose intolerance with aging (43,44). Isolated islets from
Sur
	/	 mice show impaired glucose-stimulated insulin
secretion and lack of responsiveness to tolbutamide in
vitro (43).
Which mechanism(s) is responsible for reduced Sur1
expression in both F1 and F2 islets? Since decreased Sur1
gene expression progresses to F2 offspring through the
paternal lineage, we hypothesized that reductions in Sur1
expression would be mediated, in part, by altered DNA
methylation; however, we did not observe differences in
methylation of the Sur1 proximal promoter region (sup-
plementary Fig. 2). A potential limitation of our approach
is that we utilized DNA from islets (a mixture of -, -, -,
and PP cells), potentially masking -cell–speciﬁc differ-
ences. Alternatively, reduced expression of Sur1 in islets
from F1 and F2 mice might also be due to 1) altered
methylation of another genomic region(s), 2) altered his-
tone modiﬁcation, or 3) changes in binding/expression of
other transcription factors regulating Sur1. Future exper-
iments will focus on potential mechanisms mediating
decreased expression of Sur1.
An additional factor likely to contribute to impaired
glucose tolerance in UN-UN mice is insulin resistance,
observed by age 6 months (Figs. 2B and 3B). Of note,
insulin resistance arises when both parents were growth
restricted in utero, suggesting that interface between these
two lineages is necessary and sufﬁcient to induce insulin
resistance. While the speciﬁc mechanisms underlying in-
sulin resistance in UN-UN mice remain under investi-
gation, it is interesting to note that UN-UN mice also
display increased visceral fat by age 4 months (Fig. 5A).
Therefore, it is tempting to speculate that insulin resis-
tance may develop secondary to progressive accumulation
of visceral fat in UN-UN.
Intergenerational transmission of obesity. Childhood
obesity is linked to parental obesity (45). Although it is
difﬁcult to dissect the relative contribution of shared
environmental factors to these phenotypes in humans,
maternal metabolic dysregulation during pregnancy may
be a key contributor (46,47). We similarly demonstrate
that adiposity phenotypes progress to F2 offspring through
the maternal lineage (Fig. 5A), implicating subtle maternal
metabolic dysfunction during pregnancy and/or maternal
epigenetic effects. It is important to note that despite
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similar to that of controls (Fig. 1C). Therefore, offspring of
F1-UN females do not have overt obesity but have a shift in
body composition (higher fat mass with concomitantly
reduced lean body mass) (26). On the other hand, although
paternal transmission alone is not sufﬁcient to drive adi-
posity in C-UN mice, paternal effects may contribute to
the increased abdominal fat accumulation in UN-UN
mice as compared with UN-C mice.
We next evaluated potential mechanisms mediating
increased adiposity in UN-C and UN-UN mice.
First, food intake was similar in all groups (not shown).
Second, expression of adipocyte differentiation markers,
including peroxisome proliferator–activated receptor 
,
CCAAT/enhancer binding protein , fatty acid binding
protein 4, or Glut4, was similar in all F1 and F2 groups
(supplementary Table 3) (E.I., J.C.J.-C., M. Woo, A.C., J.
DeCoste, M. Vokes, M. Liu, S. Kasif, A.-M. Zavacki, R.
Leshan, M. Myers, M.E.P., unpublished data). Similarly, we
observed no major differences in adipocyte size distribu-
tion among F2 groups (not shown). Additional studies will
be required to determine whether alterations in adipocyte
metabolic function or in systemic energy homeostasis also
contribute to adiposity.
Since obesity in UN-UN mice implicates a partial
role for epigenetic factors, it is very interesting that Pref1
expression was signiﬁcantly decreased in F1-UN, C-
UN, and UN-UN mice (Fig. 5C and D). Patrilineal
inheritance of Pref1 expression may be explained by the
fact that it is expressed from the paternally inherited
chromosome; altered expression would be predicted to be
inherited from F1-UN males but not F1-UN females. Mice
lacking functional Pref1 have increased adiposity (48);
conversely, mice overexpressing Pref1 have reduced fat
content (49) (A.F.-S., unpublished data). Thus, decreased
Pref1 expression may contribute, in part, to develop-
ment of obesity in F1-UN, UN-C, and UN-UN mice.
While our data support a potential role of Pref1 in the
development of adiposity in our mouse model, it has to be
noted that its expression has been determined in epididy-
mal fat, a depot without direct parallel in humans. Thus,
although many adipose genes are similarly expressed in
both rodents and humans (50), extrapolation of Pref1 gene
expression data from our model to humans must be
undertaken with caution.
Imprinting of Pref1 is under complex control by both
paternal and maternal alleles (28). We did not detect
changes in methylation of the differentially methylated
regions that regulate imprinting at this locus in fat from
4-month-old mice of either F1 or F2 generations (supple-
mentary Fig. 4). These data suggest that, as with Sur1,
altered expression of Pref1 is due to either changes in
expression or function of an upstream transcription factor,
histone modiﬁcation, or another yet-unknown genomic re-
gion that is epigenetically modiﬁed. Thus, additional studies
are required to deﬁne the potential role of epigenetics in
adipose development in our model.
In conclusion, we demonstrate that maternal under-
nutrition during pregnancy programs reduced birth
weight, glucose intolerance, and obesity in ﬁrst- and
second-generation offspring, even despite ad libitum
feeding during second pregnancy. Different aspects of
these phenotypes are transmitted via the maternal lin-
eage (obesity), the paternal lineage (reduced birth
weight), or both (glucose intolerance). Sex differences in
transmission of phenotypes implicate complex mecha-
nisms: 1) matrilineal inheritance of disease is multifacto-
rial and includes metabolic, epigenetic, and mitochondrial
mechanisms; and 2) patrilineal inheritance is primarily
due to epigenetic mechanisms. While we do not yet
understand the complex array of molecular mechanisms
associated with fetal programming of disease, such studies
will be of great importance for the design of future
therapeutic interventions aimed to prevent and/or modu-
late adult phenotypes, not only in LBW humans but also in
their children and grandchildren.
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